Market revenue in 2023 | USD 600.2 million |
Market revenue in 2030 | USD 1,009.0 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Viscosupplements |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Viscosupplements, Pharmaceuticals |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Elanco Animal Health Inc, Daiichi Sankyo Co Ltd, Merck & Co Inc, Vetoquinol SA, Ceva Santé Animale, Virbac SA, Biogenesis Bago, Ardent Health Services, Biomerica Inc, PetVivo Holdings, Contipro, Medrego, Hyalogic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary orthopedic medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 46.72% in 2023. Horizon Databook has segmented the U.S. veterinary orthopedic medicine market based on biologics, viscosupplements, pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The key driver responsible for the U.S. market growth is rising prevalence of osteoarthritis and other degenerative joint diseases. According to an article published by Morris Animal Foundation, in October 2023, osteoarthritis affects around 14 million adult dogs in the U.S., making it a major health problem for dog owners.
Although exact percentages for cats are still unknown, X-rays show that 90% of cats older than 12 have osteoarthritis. These figures demonstrate a significant amount of animals suffering from this illness. Chronic osteoarthritis is a joint condition resulting in pain and limb impairment.
It is identified by the formation of new bone known as osteophytosis surrounding the joint, thickening of the joint capsule, and loss of joint cartilage. Most canine osteoarthritis is caused by developmental orthopedic diseases, such as cranial cruciate ligament disease, elbow dysplasia, hip dysplasia, dislocation of the patella (kneecap), and OCD.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. veterinary orthopedic medicine market, including forecasts for subscribers. This country databook contains high-level insights into U.S. veterinary orthopedic medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account